Taylor Daphne 4
4 · Aptevo Therapeutics Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Taylor Daphne L
SVP, CFO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-03-02−2→ 2 total→ Common Stock (2 underlying) - Exercise/Conversion
Common Stock
2025-03-02+2→ 17 total - Exercise/Conversion
Common Stock
2025-03-04+1→ 18 total - Exercise/Conversion
Restricted Stock Unit
2025-03-04−1→ 0 total→ Common Stock (1 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.